Bioequivalence and Bioavailability Forum

i was reading the post from 3 months ago on the Pharsight Forum and I noticed below.

"The Phoenix WinNonlin software provides a BE module to perform average bioequivalence but this module is not currently designed for a complete RSABE analysis. However, RSABE can be performed in Phoenix WinNonlin 6.3 using reusable template projects and workflows for both EMA and FDA approaches. These template projects require minimal input from the user in order to be used with any input dataset from a replicated 3-period or 4-period crossover design. These Phoenix template projects are available for free download and the objective of this webinar is to demonstrate how they work."


I wonder if the FDA approach has been evaluated in comparison with SAS? How about dropout subjects? I thing there was a progesterone example from the FDA and it used SAS code, but I do not remember if input data was provided.

ANGUS

---

Edit: Category changed. [Helmut]